NuVasive (NUVA +5.6%) gets a pop from an upgrade to Outperform at RBC Capital. The firm says...
NuVasive (NUVA +5.6%) gets a pop from an upgrade to Outperform at RBC Capital. The firm says that the results of a recent survey of U.S. spine surgeons show the Street may be underestimating the near-term sustainability of the medical device company's U.S. lumbar revenue growth rate.
From other sites
Video at CNBC.com (Jul 13, 2016)
Video at CNBC.com (Jun 3, 2016)
at CNBC.com (Oct 4, 2012)
at CNBC.com (Oct 3, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs